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Functional Characterization of a Lipoprotein-Encoding Operon in
Campylobacter jejuni
Abstract
Background
Bacterial lipoproteins have important functions in bacterial pathogenesis and physiology. In Campylobacter
jejuni, a major foodborne pathogen causing gastroenteritis in humans, the majority of lipoproteins have not
been functionally characterized. Previously, we showed by DNA microarray that CmeR, a transcriptional
regulator repressing the expression of the multidrug efflux pump CmeABC, modulates the expression of a
three-gene operon (cj0089, cj0090, and cj0091) encoding a cluster of lipoproteins in C. jejuni.
Methodology/Principal Findings
In this work, we characterized the function and regulation of the cj0089-cj0090-cj0091 operon. In contrast to
the repression of cmeABC, CmeR activates the expression of the lipoprotein genes and the regulation is
confirmed by immunoblotting using anti-Cj0089 and anti-Cj0091 antibodies. Gel mobility shift assay showed
that CmeR directly binds to the promoter of the lipoprotein operon, but the binding is much weaker
compared with the promoter of cmeABC. Analysis of different cellular fractions indicated that Cj0089 was
associated with the inner membrane, while Cj0091 was located on the outer membrane. Inactivation of
cj0091, but not cj0089, significantly reduced the adherence of C. jejuni to INT 407 cells in vitro, indicating
that Cj0091 has a function in adherence. When inoculated into chickens, the Cj0091 mutant also showed a
defect in early colonization of the intestinal tract, suggesting that Cj0091 contributes to Campylobacter
colonization in vivo. It was also shown that Cj0091 was produced and immunogenic in chickens that were
naturally infected by C. jejuni.
Conclusion/Significance
These results indicate that the lipoprotein operon is subject to direct regulation by CmeR and that Cj0091
functions as an adhesion mechanism in C. jejuni and contributes to Campylobacter colonization of the
intestinal tract in animal hosts.
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Introduction
Campylobacter jejuni is a Gram-negative, curved or spirally shaped
bacterium with a single, polar, unsheathed flagellum at one or
both ends [1]. It is a commensal organism existing in the intestinal
tracts of a variety of wild and domestic animals, especially in birds.
C. jejuni is a leading cause of acute diarrhea in humans worldwide
[2]. The typical symptoms of Campylobacter infections in humans
include watery to bloody diarrhea, abdominal pain, fever, and
presence of leukocytes and red blood cells in feces [3]. Campylobacter
infections can also develop to Guillain-Barre´ syndrome (GBS), an
autoimmune-mediated neurodegenerative disorder which causes
acute neuromuscular paralysis [4]. The most significant source
of Campylobacter infections for humans is the consumption of
undercooked chicken.
The pathogenic process of C. jejuni in humans has not been well
understood, but can be divided into several stages [5]. Once
ingested by the host, C. jejuni survives the stresses in the stomach
and small intestine. Upon reaching to the large intestinal tract, C.
jejuni colonizes mucus layer and adheres to the intestinal cell
surface of the host gastrointestinal tract. The organism produces a
cytolethal distending toxin (CDT) and possibly other toxins, but
their role in pathogenesis is not clear [6]. Once adhered to the host
intestinal epithelial cells, C. jejuni may invade into and proliferate
within the host cells. The invasion and proliferation of the
organism inside host cells are considered the cause of cell damage
and induce host inflammatory responses, which result in diarrhea
with fecal leukocytes [7]. Occasionally C. jejuni can spread to
extraintestinal sites, such as liver, gallbladder, pancreas, uterus,
and fetal tissues [3,7].
The known putative virulence factors involved in Campylobacter
pathogenesis include flagella, lipooligosaccharide (LOS), CDT,
and outer membrane proteins [7]. Flagella aid Campylobacter to
move through the mucus layer and contribute to colonization
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and invasion [8]. LOS is involved in adherence to host cells and
serves as an endotoxin that induces host intestinal inflammatory
responses [7]. In addition, molecular mimicry of LOS to human
gangliosides is considered a key factor in the development of
GBS [9]. CDT causes cell cycle arrest and host DNA damage,
which induce host inflammatory responses [10]. The outer
membrane proteins of Campylobacter are involved in interactions
with hosts and play important roles in adherence and
colonization. CadF, a 37-kDa surface protein, binds to
fibronectins located at cell-to-cell contact regions in the
gastrointestinal epithelium. CadF is required for Campylobacter
colonization of chickens [11,12]. PEB1 is a periplasmic protein
homologous to a solute-binding component of amino acid ABC
transporters [13]. PEB1 is important for C. jejuni adherence to
human cells and colonization in the intestinal tract of mice [14].
The major outer membrane protein (MOMP), a 45-kDa porin,
adheres in vitro to human intestinal cell membranes and
fibronectin [15], but whether it is involved in in vivo adherence
is unknown. CmeABC functions as an efflux pump to extrude a
variety of substrates such as antibiotics, ions, SDS, and bile salts
[16–18]. In addition, CmeABC mediates bile resistance and is
required for C. jejuni colonization in the gastrointestinal tract of
chickens [16].
Bacterial lipoproteins have diverse functions including cell
adhesion, transport, nutrient acquisition, mating, and serum
resistance as well as stimulation of inflammatory/immune
responses in host cells [19]. C. jejuni has multiple membrane
lipoproteins predicted from the genomic sequences [19]. At
present, only four of these lipoproteins, JlpA [20] and CapA [21],
CjaA [22], and FlpA [23] have been functionally characterized in
C. jejuni. JlpA, a surface-exposed, loosely cell-associated lipopro-
tein, is involved in the interaction of C. jejuni with the surface-
exposed heat shock protein 90a (Hsp90a) of host cells and
triggers signal transduction, leading to the activation of
components (NF-kB and p38 MAP kinase) involved in host
proinflammatory responses to infections [24]. CapA is also
involved in Campylobacter adherence to host epithelial cells and
colonization in gastrointestinal tract of chicken [21]. CjaA is an
inner-membrane associated lipoprotein, and has been shown that
immunization of chickens with avirulent Salmonella strain
expressing CjaA reduced the colonization of the intestinal tract
by C. jejuni [22]. FlpA is a putative outer membrane-associated
lipoprotein, which mediates adherence to chicken and human
epithelial cells as well as chicken colonization via binding to
fibronectin [23,25].
In a previous study comparing the global gene expression
profiles of in vitro grown NCTC 11168 and its isogenic CmeR
mutant using DNA microarray [26], we found that CmeR, which
is a transcriptional repressor for the multidrug efflux pump
CmeABC [27], functions as a pleiotropic regulator modulating
the expression of multiple genes in C. jejuni NCTC 11168 [26]. In
total, 28 genes showed $2-fold changes in expression in the
CmeR-deletion mutant compared with the wild-type strain.
Among the CmeR-regulated targets were cj0089 and cj0091
encoding putative lipoproteins. cj0089 and cj0091, along with
cj0090 (also encoding a putative lipoprotein) appear to be
organized into an operon, but their detailed regulatory
mechanisms and the role in Campylobacter pathophysiology remain
unknown. Considering the fact that bacterial lipoproteins have
important functions and the majority of lipoproteins in C. jejuni
have not been characterized, we conducted both in vitro and in vivo
experiments to elucidate the regulation of the lipoprotein-
encoding operon and the functions of the encoded products in
Campylobacter adherence and colonization.
Results
Genomic organization and co-transcription of cj0089,
cj0090, and cj0091
The three genes encoding the cluster of lipoproteins are
tandemly positioned in the chromosome of C. jejuni NCTC
11168 (Figure 1A). cj0089 and cj0090 are separated by 9
nucleotides, while cj0090 and cj0091 are separated by 23
nucleotides. No predicted stem-loop structures exist between the
ORFs. According to the prediction by Petersen et al. [28], there is
a putative RpoD promoter located upstream of cj0089. The
TATA-box of this promoter is located 40 nucleotides upstream of
the cj0089 translational initiation codon (data not shown). No
promoter was predicted immediately upstream of cj0090 or
cj0091. To determine whether cj0089, cj0090, and cj0091 are
co-transcribed, RT-PCR was performed on the C. jejuni strain
using primers cj89int-F and cj91int-R (Tables 1 and 2), which span
the three ORFs (Figure 1A). A 1194-bp expected product was
amplified in the PCR reaction with the RNA and RT, while no
product was obtained in the reaction without RT, indicating that
cj0089, cj0090, and cj0091 are con-transcribed and likely organized
into an operon (Figure 1B). The operon is flanked by an upstream
gene encoding an anaerobic C4-dicarboxylate transporter (dcuA)
and a downstream gene (cj0092) encoding a hypothetical protein.
There is a potential Rho-independent transcriptional terminator
forming a 23-nucleotide stem-loop structure located immediately
downstream of dcuA (Figure 1A). Another stem-loop structure is
present downstream of cj0091 (Figure 1A). These sequence
features further support the notion that the three lipoprotein
genes form an operon.
Predicted features of the putative lipoproteins
Analysis of the predicted amino acid sequences indicated that
cj0089, cj0090, and cj0091 encode putative lipoproteins because
each of them has a typical N-terminal lipoprotein signal peptide.
LipoP algorithm [29] predicted a signal peptidase II cleavage site
at LFLTAQC for Cj0089, at FLLSAQC for Cj0090, and at
LLFSGQC for Cj0091. Cj0089 (453 amino acids), Cj0090 (122
amino acids), and Cj0091 (207 amino acids) each has a calculated
molecular mass of 51.28 kDa, 13.92 kDa, and 22.32 kDa,
respectively. The molecular masses of the mature lipoproteins,
after cleavage of the signal peptides, are predicted to be 49.4 kDa,
12.29 kDa, and 20.51 kDa, respectively. BLASTP searches
against the public non-redundant protein database (http://www.
ncbi.nlm.nih.gov/) showed that Cj0089 bears similarity (78–89%)
to tetratricopeptide TPR-2 repeat proteins found in Shewanella spp.
The functions of these tetratricopeptide TPR-2 repeat proteins
have not been characterized. Cj0089 also has a 27.4% identity to
HP0018, a hypothetical protein in Helicobacter pylori. Cj0091 is
33.5% identical to HP1457 (hypothetical protein) and has a
conserved domain similar to the collagen-binding surface adhesin,
SpaP (antigen I/II family) of Yersinia pestis biovar Orientalis [30],
where its function has not been determined empirically. Cj0090
has a 46% identity to a Helicobacter pylori protein (HP0444;
hypothetical protein). In this study, we choose to focus on
characterization of Cj0089 and Cj0091.
Production of rCj0089 and rCj0091 and their specific
antibodies
The coding sequences of cj0089 and cj0091, excluding their
signal peptides, were separately cloned into pQE-30 vector,
expressed in E. coli JM109, and the proteins purified by affinity
chromatography. Using the purified proteins, rabbit polyclo-
nal antibodies against rCj0089 and rCj0091 were produced. The
Surface Lipoproteins of Campylobacter
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Figure 1. Genomic organization and co-transcription of cj0089, cj0090, and cj0091. (A) The genes are depicted by boxed arrows. The
locations of the primers used for RT-PCR were indicated by arrows. Predicted stem-loop encoding regions are shown by vertical oval arrows. (B) RT-
PCR was performed to determine the co-transcription of cj0089, cj0090, and cj0091 using primers, cj89int-F and cj91int-R. Lane 1, no RT control; lane 2,
RNA with RT and DNA polymerase; lane 3, Positive control (DNA was used as the template).
doi:10.1371/journal.pone.0020084.g001
Table 1. Bacterial strains and plasmids used in this study.
Plasmid or strain Relevant characteristics Source
Strains
C. jejuni
NCTC 11168 Wild type [57]
Cj89- 11168 derivative, cj0089::Kanr This study
Cj91- 11168 derivative, cj0091::Kanract This study
Comp91 Cj91- complemented with pUOA18-Comp91 This study
E. coli
DH5a F-W80lacZDM15D(lacZYA-argF)U169recA1endA1hsdR17(rk
2,mk
+)phoAsupE44thi-1gyrA96relA1l2 Invitrogen
JN109 endA1 recA gyrA96 thi hsdR17(rk
2,mk
+) relA1supE44D(lac-proAB)[FreaD36proABlacIqZDM15] Promega
Plasmids
pUC19 E. coli cloning vector [58]
pUC19-89 pUC19 containing full-length cj0089, Ampr This study
pUC19-89K pUC19-89 derivative carrying cj0089::Kanr This study
pUC19-91 pUC19 containing full-length cj0091, Ampr This study
pUC19-91K pUC19-89 derivative carrying cj0091::Kanr This study
pRY112 E. coli-C. jejuni shuttle vector, Cmr [52]
pRY112-Comp91 pRY112 containing containing the promoter region of cmeABC and full-length Cj0091 This study
pUOA18 E. coli-C. jejuni shuttle vector, Cmr [53]
pUOA18-Comp91 pUOA18 containing containing the promoter region of cmeABC and full-length Cj0091 This study
pMW10 E. coli-C. jejuni shuttle vector with promoterless E. coli lacZ gene, Kanr [51]
doi:10.1371/journal.pone.0020084.t001
Surface Lipoproteins of Campylobacter
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anti-Cj0089 antibody recognized a protein with a molecular mass
of 49 kDa in NCTC 11168. On the other hand, anti-Cj0091
recognized a protein with a molecular mass of approximately
18 kDa, slightly smaller than the calculated mass of Cj0091
(20.51 kDa) (data not shown). These immunoblotting results
indicated that both lipoproteins were produced in C. jejuni when
grown in MH broth.
Regulation of cj0089 and cj0091 by CmeR
In a previous DNA microarray study by our research group
[26], it was found that cj0089 and cj0091 were down-regulated in
the cmeR mutant, suggesting that CmeR activates the expression of
the lipoprotein genes. To confirm the previous finding at the
protein level, the expression levels of Cj0089 and Cj0091 in the
wild-type strain and in the cmeR mutant were analyzed by
immunoblotting using anti-rCj0089 and anti-rCj0091 antibodies.
The same amount of total proteins was loaded in each lane and
additionally MOMP (a major outer membrane protein present in
all C. jejuni isolates) was used as in internal control for protein
loading in each lane. The immuoblotting results clearly showed
that the production of Cj0089 and Cj0091 in the cmeR mutant was
decreased compared with that in the wild-type (Figure 2).
According to the densitometric analysis of immunoblots using
AlphaEaseH software (Alpha Innotech), the band intensity of
Cj0089 was 2.98 fold higher in the wild-type than that in the cmeR
mutant, and the band intensity of Cj0091 was 1.92 fold higher in
the wild-type than that in the cmeR mutant. The immunoblotting
data further confirmed the results of the DNA microarray and
real-time RT-PCR [26].
To determine if CmeR directly or indirectly regulates the
lipoprotein operon, a gel mobility shift assay (EMSA) was performed
using rCmeR and the promoter sequence upstream of cj0089. The
promoter DNA was amplified with primers Pcj89-F1 and Pcj89-R1
(Table 2). rCmeR bound to the promoter region of the lipoprotein
operon (Figure 3). However, the binding was significantly weaker
compared with that of the cmeABC promoter, suggesting that CmeR
has a low affinity to the lipoprotein promoter. Regardless, the
finding from EMSA suggests that this lipoprotein operon is subject
to direct regulation by CmeR.
Cj0089 and Cj0091 are membrane-associated proteins
In order to determine the cellular localization of Cj0089 and
Cj0091, C. jejuni strain NCTC 11168 was fractionated to isolate
proteins from the cytosol, periplasm, inner membrane, and outer
membrane. The fractions were examined by immunoblotting with
anti-rCj0089 and anti-rCj0091 antibodies (Figure 4). Cj0089 was
detected predominantly in the inner membrane fraction while
Cj0091 was found in both the inner and outer membrane
fractions, but the majority of Cj0091 was in the outer membrane.
Antisera against rCmeB, an inner membrane drug transporter of
multidrug efflux pump CmeABC [16], and against the recombi-
Table 2. Primer sequences used in this study.
Primers Sequences
cj0089-F5 59-GAGgcatgcCCGACTTTGTTAGGTGCAGTGCAA-39 (SphI)
cj0089-R5 59-GCAgagctcGCTGGAATTCTAAGGGCTTGATAGTCCT-39 (SacI)
cj89-U2 59-GCTccatggTGCCTTATCTTGACGCATTAAAACACG-39 (NcoI)
cj89-L2 59-CAGccatggGGGAAGCTTCTTTTGCAAATTTAAATATAAATGG-39 (NcoI)
cj0091-F2 59-GTGCGTtctagaAGAGGTTTACCAAAAAGTA-39 (XbaI)
cj0091-R2 59-CTTTTGGgagctcATCAAATTCCTTAGCATTCGTA-39 (SacI)
cj0089F 59-AGTggatccTGCCTTTTTTTAACAGCTTGTG-39 (BamHI)
cj0089R 59-GAGgagctcTTATTTTTCCATGATAGCAAC-39 (SacI)
cj0091-F1 59-AGTggatccTGTGCGCAAACAGCTTATACAGATGGAAAG-39 (BamHI)
cj0091-R1 59-GAGgagctcTTACCAAGTAACTGATTTACTAGAACCGGTTTTATC-
39(SacI)
Pcj89-F1 59-AGGCTTTGTATTAGCTCCTATGCTTAT-39
Pcj89-R1 59-CAAGCAATACCTGAAAAAATCAACCCAA-39
Cj89int-F 59-TTTAAAATAAATATGCCTGCAATGA-39
Cj89int-R 59-GCGATACCAATGTCCCTTTTT-39
KanNco-F 59-CTTATCAATATATccatggAATGGGCAAAGCAT-39(NcoI)
KanNco-R 59-GATAGAAccatggATAATGCTAAGACAATCACTAAA-39(NcoI)
Comp91-F2 59-CAAccgcggATGATTTTAGATTAGAAATTAAAGCAA-39(SacI)
Comp91-R2 59-GCCCgagctcAACACTTGAGCTAAAA-39(SacII)
Comp91-F3 59-GCTtctagaTGGAATCAATAGCTCCAAAGCTTAA-39(XbaI)
*The restriction sites in the sequences are indicated by lower cases. The
corresponding restriction enzymes for the restriction sites were indicated in
parenthesis.
doi:10.1371/journal.pone.0020084.t002
Figure 2. Effect of cmeR mutation on the expression of Cj0089
and Cj0091 as determined by immunoblotting.Whole cell lysates
of strains NCTC 11168 (lane 1) and the cmeR mutant (lane 2) were
separated by SDS-PAGE and probed with anti-rCj0089 (panel I), anti-
rCj0091 (panel II), and anti-rMOMP (panel III). MOMP, a 45-kDa outer
membrane protein, was used as an internal control for protein loading.
doi:10.1371/journal.pone.0020084.g002
Figure 3. Binding of rCmeR to the promoter DNA of the
lipoprotein operon as determined by EMSA. The positive control
DNA (promoter of cmeABC; lanes 1 to 3), negative control DNA (coding
sequence of cmeB; lanes 4 to 6), and the promoter DNA of the
lipoprotein operon (lanes 7 to 9) are included in the same gel. In the
reactions, a fixed amount of DIG-labeled DNA (0.02 pmol) was
incubated with 0 (lanes 1, 4, and 7), 20 (lanes 2, 5, and 8), or 40 ng
(lanes 3, 6, and 9) of rCmeR, respectively. The position of the DIG-
labeled DNA (D) and DNA-rCmeR complex (D/P) are indicated.
doi:10.1371/journal.pone.0020084.g003
Surface Lipoproteins of Campylobacter
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nant major outer membrane protein (MOMP) [31], were used as
controls for the membrane fractions. CmeB is exclusively detected
in the inner membrane fraction; however, MOMP was detected in
both outer membrane and inner membrane fractions, with the
majority of MOMP was being in the outer membrane fraction
(Figure 4). The results from the controls suggested that the inner
membrane fraction contained some outer membrane proteins,
while the outer membrane fraction was pure. Based on the blotting
results and in reference to the controls, it was concluded that
Cj0089 is associated with the inner membrane, while Cj0091 is
associated with outer membrane of C. jejuni.
Cj0089 and Cj0091 were inactivated in the insertional
mutants
To study the functions of the lipoproteins, insertional mutants of
cj0089 and cj0091 were generated (Figure 5A). Correct insertion
and orientation of the KanR cassette in Cj892 and Cj912 were
confirmed by PCR (Figure 5B). The disruptions of cj0089 and
cj0091 were also confirmed by immunoblotting using anti-rCj0089
and anti-rCj0091 (Figure 5C). In Cj892, the expression level of
cj0091 was significantly decreased, but was not abolished
(Figure 5C, panel II, lane 2), indicating that the insertion in
cj0089 caused a partial polar effect on cj0091.
Figure 4. Localization of Cj0089 and Cj0091 in C. jejuni. The
cytosol fraction (lane 1), periplasmic fraction (lane 2), inner membrane
fraction (lane 3), and outer membrane fraction (lane 4) were separated
by SDS-PAGE and probed with anti-rCmeB (panel I), anti-rCj0089 (panel
II), anti-rMOMP (panel III), and anti-rCj0091 (panel IV), respectively.
doi:10.1371/journal.pone.0020084.g004
Figure 5. Generation of deletional and insertional mutations in cj0089 and cj0091. (A) Schematic diagram of the locations of deletional and
insertional mutations. The genes are indicated by boxed arrows. The locations of the KanR insertion are indicated as solid arrows. (B) PCR confirmation
of the insertions in Cj892 and Cj912. Lanes 1, cj0089 in wild-type strain; lane 2, cj0089 in Cj892; lane 3, cj0091 in wild-type strain; and lane 4, cj0091 in
cj912. (C) Immunoblotting analysis of protein production in various constructs. Wild-type (lane 1), Cj892(lane 2), and Cj912(lane 3) were separated by
SDS-PAGE and probed with anti-rCj0089 (panel I), anti-rCj0091 (panel II), and anti-rMOMP (panel III). MOMP, a 45-kDa outer membrane protein, was
used as a loading control.
doi:10.1371/journal.pone.0020084.g005
Surface Lipoproteins of Campylobacter
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Cj0091 is required for Campylobacter adherence to INT
407 cells in vitro
Since the results indicated that Cj0091 is an outer membrane-
associated protein and has a domain homologous to SpaP involved
in surface adherence, it is possible that Cj0091 is involved in the
interaction between C. jejuni and host cells. To examine this
possibility, the ability of NCTC 11168 wild type strain and the two
isogenic mutants, Cj892 and Cj912, to adhere to the monolayers
of human intestinal cell line INT 407 was measured (Figure 6).
Cj912 showed a 4.3-fold reduction in adherence compared with
the wild-type strain (P,0.05). Cj892 had a 1.3-fold reduction in
adherence compared to the wild-type; however, the difference was
not significant (p.0.05). The adherence ability of the comple-
mented strain of Cj912, Comp91, to INT 407 cell line was
restored partially to the wild-type level (Figure 6). To rule out the
possibility that the observed phenotype of Cj912 was due to its
increased sensitivity to Triton X-100 (used in the adhesion assay to
dissociate bacteria from the INT 407 cells), both the wild-type and
Cj912strains were treated with 1% Triton X-100 for 20 min and
then the treated bacteria were plated onto MH agar plates for
CFU counts. The result indicated that both strains were equally
resistant to the treatment with Triton X-100 (result not shown).
These findings indicate that Cj0091, but not Cj0089 has a
significant role in Campylobacter adherence to INT 407 cells.
Cj0091 is involved in intestinal colonization in chicken
To test whether Cj0089 and Cj0091 had a role in chicken
colonization, the wild-type strain 11168, its isogenic mutants
Cj892 and Cj912, and Comp91 were separately inoculated into
four groups of chickens. At necropsy, cecal contents were collected
on DPI 3, 6, and 9 from 5 chickens from each group and cultured
for enumeration of Campylobacter using selective plate counting. On
DPI 3 and 6, the mean level of colonization by Cj912 was
substantially lower (reduced approximately 2.8 and 2.7 log10 units,
respectively) than that of the wild-type strain (Figure 7). The
differences were statistically significant (p,0.05). However, on
DPI 10 no significant differences in colonization between the wild-
type and Cj912 were observed. The level of colonization was
restored to the wild-type level in the complemented strain,
Comp91 (Figure 7). Throughout the experiment, no differences
in colonization were observed between the wild-type and Cj892
(Figure 7). The colonization reduction seen with Cj912 was not
attributable to the difference in in vitro growth rates or motility
because growth and motility of the mutants were equally
comparable to those of the wild-type strain (data not shown).
Together, these results indicate that Cj0091, but not Cj0089,
contributes to the establishment of colonization during the early
stages of C. jejuni infection in the intestinal tract of chickens.
Cj0091 is expressed and immunogenic in chickens
The contribution of Cj0091 to adherence and in vivo
colonization prompted us to determine if Cj0091 was produced
and immunogenic in chickens naturally infected by Campylobacter.
For this purpose, rCj0091 was used as antigen in immunoblotting
and was probed with chicken sera collected from 5 individual
Figure 6. Adherence of C. jejuni strain NCTC 11168 and the
mutants to INT 407 cells. Strain NCTC 11168, Cj892, and Cj912 were
inoculated onto monolayers of INT 407 cells and the percentages of
adherent bacterial cells were calculated by viable plate counts. Each
experiment was conducted in quadruplicate and repeated for 3 times.
Bars and error bars indicate the mean 6 standard deviation. * indicates
significant differences in colonization levels at P,0.05 level as
determined by Student’s t-test.
doi:10.1371/journal.pone.0020084.g006
Figure 7. Colonization of C. jejuni strain NCTC 11168 and its mutants in chickens. Approximately 107 CFU of each of NCTC 11168 (solid
squares), Cj892(open circles), Cj912 (solid triangles), Comp91 (solid diamonds) were inoculated into 3-day-old chickens. Cecal contents were
collected on 3, 6, and 10 days post inoculation (DPI) and enumerated by plate counts. Each symbol represents the colonization level in a single bird.
The mean for each group is depicted by a horizontal bar. The detection limit of the plating method is about 100 CFU/g of feces. An asterisk indicates
significant differences in colonization levels at P,0.05 as determined by Student’s t-test.
doi:10.1371/journal.pone.0020084.g007
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chickens, among which 4 contained natural maternal antibodies
against C. jejuni and the other one was a negative control
(Campylobacter-free and no anti-Campylobacter maternal antibodies)
[32]. As shown in Figure 8, the 21-kDa rCj0091 was detected by
the 4 sera, in which high level of C. jejuni-specific maternal
antibodies (IgG) were present, but not by the serum in which the
C. jejuni-specific maternal antibodies were absent (Figure 8). These
findings strongly suggest that Cj0091 was produced and
immunogenic during the colonization of chickens by C. jejuni.
Discussion
In this study, we characterized an operon encoding three
lipoproteins, Cj0089, Cj0090, and Cj0091. It was confirmed that
this operon is activated and directly regulated by CmeR, a
pleiotropic regulator modulating the expression of multiple genes
with diverse functions in Campylobacter [26]. We also demonstrated
that Cj0091, but not Cj0089, plays an important role in mediating
Campylobacter adherence to INT 407 cells and in Campylobacter
colonization of the gastrointestinal tract of chickens, especially in
the early stage of the infection. These findings identify a new
adhesion mechanism in C. jejuni and provide new insights into the
pathogenesis of C. jejuni.
Homology searches using BLASTP showed that Cj0089 is
similar to the tetratricopeptide TPR-2 repeat protein of Shewanella
spp. (78–89% homology; E-value = 4e-19 to 4e-16). The tetra-
tricopeptide repeat (TPR) is a structural motif, which mediates
protein-protein interactions. TPR-containing proteins have
diverse functions such as regulation of the cell cycle, protein
transport, the regulation of transcription, splicing events, and
protein folding [33,34]. Proteins containing the TPR motif have
been found in various organisms including bacteria, yeast, plants,
insects, and animals [33,34]. At present the function of Cj0089 is
unknown, and the function of Cj0090 has yet to be determined.
Since cj0089, cj0090, and cj0091 form an operon, it is possible
that the three encoded products have a functional link. This
possibility remains to be defined in future studies. Cj0091 has a
conserved domain homologous to the collagen-binding surface
adhesin, SpaP (antigen I/II family) of Y. pestis biovar Orientalis.
spaP was first identified in Streptococcus mutans as a gene encoding
antigen I/II [35] and is also known as P1 [36]. The antigen P1,
encoded by spaP, plays a role in adherence of S. mutans to the
salivary pellicle of tooth surfaces or to other microorganisms
[37,38]. At this stage, it is unknown if Cj0091 binds to collagen or
has functions similar to those of SpaP in S. mutant. It should be
mentioned that Cj0089 and Cj0091 are putative lipoproteins as
supported by bioinformatics analyses and membrane association
experiments, and further studies such as palmitoylation assay
using [3H]-palmitate are needed to prove that they are truly
modified by lipids.
In this study we confirmed the regulation of the putative
lipoprotein operon by CmeR (Figures 2 and 3). Based on the result
of EMSA, CmeR directly interacts with the promoter DNA
(Figure 3). However, the interaction is much weaker compared
with the cmeABC promoter, suggesting that CmeR is a secondary
regulator of the lipoprotein operon. This notion is supported by
the fact that the fold change in expression of the lipoprotein genes
was moderate as determined by microarray, real-time RT PCR,
and immunoblotting. Analysis of the upstream sequence of cj0089
did not identify the typical inverted repeat found in the promoter
region of cmeABC recognized by CmeR [27]. Since CmeR serves
as an activator for the lipoprotein operon, which is in contrast to
the regulation of cmeABC (repressed by CmeR), the binding site for
CmeR in front of the lipoprotein operon could be different from
the one upstream cmeABC. This possibility awaits further
inverstigation.
The contribution of Cj0091 to Campylobacter adherence was
investigated using the human intestinal epithelial cell line INT 407
(Figure 6). So far, adhesins characterized in C. jejuni include PEB1
[14], CadF [11], MOMP [15], JlpA [20], CapA [21], FlpA [23],
and Cj1349c [23]. PEB1 is a periplasmic protein, homologous to
the periplasmic solute-binding protein component of amino acid
ABC transporters [13]. An important function of PEB1 is that it
binds to aspartate and glutamate, which are important sources of
carbon and energy for Campylobacter [13,39]. CadF, a surface
protein, is involved in the binding of C. jejuni to fibronectin in the
host gastrointestinal epithelium and stimulation of the host cell
signal transduction pathway [11,40]. MOMP, a trimeric outer
membrane protein [41,42], is involved in pore-forming activity
[43], and assists outer membrane structural organization and
stabilization [44]. Although one study suggested MOMP could be
involved in adherence [15], the exact role of MOMP in the
interaction between Campylobacter and host cells is unknown. JlpA is
a lipoprotein and is involved in interaction with host cells in vitro
[20]. Besides functioning as an adhesin, JlpA interacts with
surface-exposed heat shock protein 90a (Hsp90a) on host cells,
triggering signaling pathways and leading to the activation of NF-
kB and p38 MAP kinase [24]. CapA, which is an autotransporter,
is involved in the colonization of the chicken gut and plays a role
in adherence to human epithelial cells [21]. FlpA contains Fn type
III domains, and is involved in interaction with host cells in vitro
and in vivo via binding to fibronectin [23,25]. Cj1349c has been
shown to be involved in adherence to chicken liver epithelial cells
[23]. Thus, C. jejuni appears to possess multiple adhesins and the
Figure 8. Immunoblotting detection of natural anti-Cj0091
antibodies in chickens. Strips of nitrocellulose membranes with
rCj0091 were reacted with 4 chicken sera (lanes 2–5) that contained
Campylobacter-specific maternal antibodies derived from natural
infections and one chicken serum (lane 6) that was negative for anti-
Campylobacter antibodies. Anti-rCj0091 was applied as a positive
control (lane 1).
doi:10.1371/journal.pone.0020084.g008
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partial reduction of adherence seen with Cj912 may be explained
by the complementary effects of other adhesins.
Although we showed that Cj0091 is an outer membrane
associated protein (Figure 4), it has yet to be determined whether
this protein is located on the outer surface or is facing the
periplasmic space. Controlled protease treatments did not yield
conclusive result on the surface exposure of Cj0091 (data not
shown). Therefore, it is uncertain how Cj0091 contributes to
Campylobacter adherence to human epithelial cells. More advanced
technologies (such as immunogold labeling and electron micros-
copy) may be used in future work to ascertain the exact location of
Cj0091 on the outer membrane. It should be pointed out that not
all adhesins are true outer surface exposed proteins. For example,
PEB1 and CjaA are reported adhesins of Campylobacter and are
mainly localized in the periplasmic space or inner membrane, but
these proteins are shown to be secreted or attached on the outer
surface, functioning as adhesins [22,55]. Thus, even if Cj0091
faces inward on the outer membrane, this would still not exclude
its role as an adhesin.
C. jejuni mainly colonizes in cecal and cloacal crypts in chickens
[45,46]. Unlike the colonization in mammals, such as mice, swine,
rabbits, monkeys, and humans, where the organism commonly
invades the host intestinal epithelial cells, C. jejuni does not usually
invade the intestinal epithelium of chickens [47–49]. Thus, surface
colonization is an important feature of Campylobacter infection in
chickens. Ceca of chickens are blind-ended sacs filled with small
food particles, fluid, and microorganisms. Cecal contents are
constantly moving and periodically evacuated [50]. Thus, cecum is
not a stagnant environment and Campylobacter must possess
mechanisms for persistent colonization in this niche. Interestingly,
the differences in colonization between the wild-type and Cj912
were only seen at the early stage (before DPI 10) of infection
(Figure 7). We speculate that this may reflect the possibility that
Cj0091 is only required for the initial adherence and optimal
establishment of infection, or that adaptation of the Cj912 mutant
occurs in the intestinal tract, overcoming the early defect in
colonization. Although it has been reported that Campylobacter does
not directly interact with intestinal epithelial cells, but rather
resides in the mucus layer of the crypts moving freely and rapidly
in chickens [46], it is highly likely that adherence to the
gastrointestinal mucosal cell surface is still required for successful
colonization in chickens [7]. Indeed, independent studies have
shown that CapA, CadF, PEB1, and FlpA are each required for
Campylobacter colonization in chickens [12,14,21,23].
It was demonstrated in this study that Cj0089 is an inner
membrane protein (Figure 4). Disruption of cj0089 did not result in
significant changes in in vitro adherence and in vivo colonization
(Figures 6 and 7), suggesting that Cj0089 is not essential for
Campylobacter growth in the intestinal tract. Alternatively, it may
suggest that Cj0089 shares redundant function(s) with other genes
in C. jejuni. Although cj0089 and cj0091 are located in the same
operon and both are regulated by CmeR, they may have different
functions in Campylobacter biology. Interestingly, mutation of cj0089
reduced, but did not abolish, the expression of cj0091 due to a
polar effect (Figure 5). The partial reduction in Cj0091 expression
did not cause an apparent phenotypic change, suggesting that
partial production of Cj0091 is sufficient for adherence and
colonization at the wild-type level.
Another interesting finding in this study is that Cj0091 is
abundant in C. jejuni in vitro and is apparently immunogenic in
chickens (Figure 8). To date, no commercial vaccines against
Campylobacter are available for use in humans or poultry, but some
promising candidates have been evaluated for potential develop-
ment of vaccine products [5,22]. The fact that the Campylobacter is
commensal in poultry and that it shows high genetic and antigenic
diversity among different strains make the development of an
effective vaccine quite difficult. One of the promising vaccine
candidates is an attenuated Salmonella strain carrying the C. jejuni
CjaA antigen [22]. CjaA is a highly immunogenic protein that is
well conserved among different Campylobacter serotypes and induces
protective immune responses in chickens [22]. Cj0091 is also
highly conserved among the 4 sequenced strains of C. jejuni ($99%
amino acid identity). This fact plus the findings from this study
suggest that Cj0091 may be used as a potential vaccine candidate
in the control of C. jejuni colonization in chickens. This possibility
will be examined in future studies.
Materials and Methods
Bacterial strains, plasmids, and culture conditions
The various bacterial strains, mutants, and plasmids used in this
study are listed in Table 1. Campylobacter strains were routinely
grown in Mueller-Hinton (MH) broth (Difco, Detroit, MI) or agar
at 42uC with an atmosphere of 5% O2, 10% CO2, and 85% N2.
Escherichia coli strains were grown is Luria-Bertani (LB) broth
(Difco) or agar at 37uC with shaking at 250 rpm. Media were
supplemented with ampicillin (Amp) (100 mg/ml), kanamycin
(Km) (50 mg/ml), or chrolamphenicol (Cm) (4 mg/ml for Campylo-
bacter, 20 mg/ml for E. coli) as needed.
PCR
All primers used for PCR are listed in Table 2. PCR
amplification was performed in a volume of 100 ml containing
200 mM of each deoxynucleoside triphosphate, 200 nM primers,
2.5 mM MgSO4, 100 ng of template DNA and 5 U of Taq DNA
polymerase (Promega, Madison, WI) or pfu Turbo DNA polymer-
ase (Stratagene, La Jolla, CA). Cycling conditions varied de-
pending on the estimated melting temperatures of the primers and
the expected size of the products. PCR products were purified with
a QIAquick PCR purification kit (QIAGEN, Valencia, CA). For
reverse transcriptase PCR (RT-PCR), total RNA was isolated
from C. jejuni NCTC 11168 using the RNeasy minikit (QIAGEN).
Isolated total RNAs were treated with RNase-free DNase
(QIAGEN) to remove contaminating genomic DNA, and this
was followed by quantification and qualification of the RNA using
a NanoDrop microscale spectrophotometer (NanoDrop Technol-
ogies, Wilmington, DE). RT-PCR was conducted using the
SuperScriptTM III One-Step RT-PCR system with PlatinumH
Taq DNA Polymerase (Invitrogen, Carlsbad, CA). Cycling
conditions for the RT-PCR were as follows: synthesis of cDNA
at 50uC for 30 min; denaturation at 94uC for 2 min, followed by
40 cycles of 94uC for 15 s, 55uC for 30 s and 72uC for 2 min 30 s;
and a final extension at 72uC for 10 min. The negative control was
a RT-PCR mixture with the Taq polymerase (Promega) without
the RT step, while the positive control was a reaction with
genomic DNA as the template.
Production of rCmeR
Full-length recombinant CmeR was produced in E. coli as
described previously [26,27] with some modifications. Specifically,
the two cysteine residues in CmeR (C69 and C166) were replaced
by serine using site-directed mutagenesis to increase the stability of
purified CmeR. The mutagenesis was performed using the
QuikChange II site-directed mutagenesis kit (Stratagene). Com-
plimentary primers CmeRC1-F (59-GAAATTTTAGATGA) and
CmeRC1-R (59-GATGAAAGTGTTTTTTACTTATGTCAT-
CTAAAATTTC-39) were used to generate the C69S mutation,
while primers CmeRC2-F (59-CTTGCTGTTCTTTTTAGCAC-
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TATGTTAAAAGAACC-39) and CmeRC2-R (59-GGTTCTTT-
TAACATAGTGCTAAAAAGAACAGCAAG-39) were used to
generate the C166S mutation. The reaction was performed in a
50 ml mixture containing 5 ml of 10 6 reaction buffer, 50 ng of
purified pQE11168CmeR plasmid (cmeR cloned into pQE30) [27],
1 ml of each of the 10 mM primers (CmeRC1-F, CmeRC1-R,
CmeRC2-F, and CmeRC2-R), 1 ml of dNTP mix, 1 ml of PfuUltra
HF DNA polymerase (2.5 U/ml) and ddH2O. The temperature
cycling used for synthesis and amplification started with 1 cycle at
95uC for 30 s and then followed by 18 cycles (95uC for 30 s, 55uC
for 1 min, and 68uC for 4 min). The reaction was then cooled on
ice for 2 min. In order to digest the parental DNA, 1 ml of the Dpn
I restriction enzyme (10 U/ml) was added directly to the
amplification reaction, which was then gently mixed and
incubated at 37uC for 1 hour. Then, the Dpn I-treated DNA
was transformed into competent E. coli JM109 cells. Positive
colonies were selected on LB Agar plate containing ampicillin
(100 mg/ml). The mutated plasmids were isolated and the desired
mutations were confirmed by DNA sequencing. The rCmeR
carrying the C69S and C166S changes were produced, purified
and used for DNA binding assay as described previously [26].
Deletional mutation of cj0089
An isogenic cj0089 mutant was constructed by deletional
mutagenesis in C. jejuni strain NCTC 11168. To construct the
cj0089mutant, primers cj0089-F5 and cj0089-R5 (Table 2) were used
to amplify the 1915-bp fragment containing the entire open reading
frame (ORF) of cj0089 (1362 bp) and its flanking sequences from C.
jejuni strain NCTC 11168 chromosomal DNA. The PCR product was
digested with SphI and SacI and cloned into pUC19 (Invitrogen) to
form pUC19-89. Inverse PCR was performed using pfu Turbo DNA
polymerase (Stratagene) on pUC19-89 using primers cj89-U2 and
cj89-L2 (Table 2), which resulted in a 460-bp deletion within cj0089. A
kanamycin-resistance (KanR) cassette, amplified from pMW10 [51] by
pfu Turbo DNA polymerase (Stratagene), was inserted into the
amplified product to obtain pUC19-89K. The suicide vector,
pUC19-89K, was introduced into C. jejuni NCTC 11168 by
electroporation. Transformants were selected on MH agar containing
Km (50 mg/ml). Disruption of cj0089 by deletion of the partial ORF
and insertion of the KanR gene with the correct orientation was
confirmed by PCR, and the cj0089 mutant was named Cj892.
Insertional mutation of cj0091
An isogenic cj0091 mutant was constructed by insertional
mutagenesis in C. jejuni NCTC 11168. The 1724-bp fragment
containing the entire ORF of cj0091 (624 bp) and its flanking
sequences was amplified using primers cj0091-F2 and cj0091-R2
(Table 2) from C. jejuni NCTC 11168 chromosomal DNA. The
PCR product was digested with SacI and XbaI and cloned into
pUC19, forming pUC19-91. pUC19-91 was digested with ClaI
followed by Klenow treatment (Takara, Shiga, Japan) to form
blunt ends. The KanR cassette, amplified from pMW10 by pfu
Turbo DNA polymerase (Stratagene), was inserted into the ClaI-
digested and Klenow-treated pUC19-91 to obtain pUC19-91K.
The suicide vector, pUC19-91K, was introduced into C. jejuni
NCTC 11168 by electroporation. Transformants were selected on
MH agar containing 50 mg of Km per ml. PCR was performed to
confirm the disruption of cj0091 by the KanR gene with the right
orientation, and the cj0091 mutant was named Cj912.
Complementation of Cj912
To construct the complement of Cj912, primers 91comp-F2
and 91comp-R2 (Table 2) were first used to amplify the 744-bp
fragment containing the entire ORF of cj0091 (624 bp) and its
flanking sequences from C. jejuni strain NCTC 11168 chromo-
somal DNA. The PCR product was digested with SacI and SacII
and cloned into pRY112 [52], containing the promoter region of
cmeABC to form pRY112-Comp91. Primers 91comp-F3 and
91comp-R2 were used to amplify the fragment containing the
promoter region of cmeABC and entire ORF of Cj0091 from
pRY112-comp91. The amplified product was digested with SacI
and XbaI and cloned into pUOA18 [53] to form pUOA18-
Comp91. The vector, pUOA18-Comp91, was introduced into
Cj912 by conjugation. Transformants were selected on MH agar
containing 50 mg of Km per ml and 4 mg of Cm per ml. PCR and
immunoblotting were performed to confirm the complementation
of Cj912, and the complement of Cj912 was named Comp91.
Expression and purification of recombinant Cj0089 and
Cj0091
6 x histidine (His)-tagged recombinant Cj0089 and Cj0091
(rCj0089 and rCj0091, respectively) were produced in E. coli using
the pQE-30 vector of the QIAexpress System (QIAGEN). A 1323-
bp sequence (not including the N-terminal lipoprotein signal
peptide sequence) of cj0089 (1362 bp) was amplified using primers
cj0089F and cj0089R (Table 2). A 567-bp fragment (without the
N-terminal lipoprotein signal peptide sequence) of cj0091 (624 bp)
was also amplified using primers cj0091-F1 and cj0091-R1
(Table 2). The amplified products containing restriction sites at
the 59-ends (Table 2) were purified and digested with appropriate
restriction enzymes and separately ligated into pQE-30 vectors.
The predicted lipoprotein signal peptides of Cj0089 and Cj0091
were not included in the recombinant products. Thus, the
recombinant products represented the mature proteins in C. jejuni.
Cloning, expression and purification of rCj0089 and rCj0091 were
performed using the procedures provided by the QIAexpress
system. The purified proteins were washed with 1 x PBS
(containing 10 mM benzamidine) to remove imidazole and were
concentrated using UltracelHYM-30 (for Cj0089) and Ultracel-
HYM-10 (for Cj0091) Centrifugal Filter Units (Millipore, Billerica,
MA).
Production of rabbit antisera
A polyclonal rabbit antiserum against rCj0089 was generated in
our laboratory. A New Zealand white rabbit was immunized three
times with rCj0089 at a 2-week interval between the injections.
Each immunization used 100 mg of rCj0089 emulsified in
incomplete Freund’s adjuvant. The animal was sacrificed 21days
after the last injection to collect the antisera against rCj0089.
Polyclonal antiserum against rCj0091 was generated in two rabbits
by Pacific Immunology Corp (San Diego, CA, USA). The antisera
were stored at 280uC for further use.
Electrophoretic mobility shift assays (EMSA)
To determine whether CmeR directly binds to the operator
region of cj0089, EMSA, as described by Alekshun et al. [54], was
performed with slight modifications. The 179-bp promoter region of
cj0089 was amplified using primers Pcj89-F1 and Pcj89-R1
(Table 2). The amplified product was then labeled at the 39 end
with digoxigenin-11-ddUTP (DIG-11-ddUTP) using the DIG
Oligonucleotide 39-End Labeling kit (Roche Molecular Biomedi-
cals, Indianapolis, IN). The DIG-11-ddUTP-labeled DNA
(0.02 pmol) was incubated with different amounts of rCmeR (0,
20, and 40 ng) in 20 ml binding buffer containing 20 mM HEPES
(pH 7.6), 1 mM EDTA, 10 mM (NH4)2SO4, 5 mM dithopthreitol,
0.2% Tween-20, 30 mM KCl, and 50 ng of poly(dI-dC). The
reaction mixtures were incubated at room temperature for 30 min,
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followed by electrophoresis on a nondenaturing 6% (w/v)
polyacrylamide gel in a 0.5 x TBE buffer (44.5 mM Tris,
44.5 mM boric acid, 1 mM EDTA, pH 8.0) at 200 V for 45 min.
The DNAwas transferred from the gel to a positively charged nylon
membrane using a vacuum blotter. Alkaline phosphatase-conjugat-
ed anti-DIG antibody and the chemiluminescent substrate CDP-
star (Roche Molecular Biochemicals) were sequentially applied to
the membrane. The chemiluminescence signals on the blots were
captured using a digital imaging system (ChemiImagerTM5500 from
Alpha Innotech, San Leandro, CA). The promoter DNA of cmeABC
and the intragenic fragment of cmeB were used as the positive and
negative controls, respectively, as described in a previous study [27].
Preparation of cell fractions
The cell fractions of cytoplasm, periplasm, inner membrane, and
outer membrane were obtained using the method described by
Leon-Kempid et al. [55], with slight modifications. In total, 500 ml
of an overnight culture of C. jejuni strain NCTC 11168 were
harvested by centrifugation at 5000 x g for 30 min, and the cell
pellet was resuspended in 20 ml of the ST buffer (20% w/v sucrose,
30 mM Tris-HCl, pH 8.0) at room temperature. EDTA was added
to the cell suspension to a final concentration of 1 mM and the
suspension was incubated for 10 min at room temperature with
shaking. The cells were then centrifuged at 8000 x g for 10 min at
room temperature to collect the cell pellet. The supernatant was
discarded. The pellet was resuspended and stirred in ice-cold
10 mM Tris-HCl (pH 7.5) at 4uC for 10 min followed by
centrifugation at 15,000 x g at 4uC for 15 min. The supernatant
was concentrated by 10%TCA and kept as the periplasmic fraction.
The pellet was again resuspended in 5 ml of ice-cold 10 mM Tris-
HCl (pH 7.5), followed by sonication (Virsonic, an SP Industries
Company, Warminster, PA) by three bursts of 30 s at 6 mm
amplitude and centrifugation at 13,000 x g at 4uC for 15 min. The
pellet was discarded. The supernatant was ultracentrifuged at
100,000 x g at 4uC for 1 hour. The supernatant was then
transferred to a new tube and again centrifuged at 100,000 x g at
4uC for 1 hour. The supernatant was concentrated by 10% TCA,
corresponding to the cytoplasmic fraction. The pellet collected was
the total membrane fraction. The isolation of inner and outer
membrane was performed using the method of Carlone et al. [56].
The pellet of membrane fraction was washed three times with ice-
cold 10 mM Tris-HCl (pH 7.5) and resuspended in 0.2 ml of
10 mMHEPES buffer (pH 7.4). An equal volume of sarkosol buffer
(2% sodium N-lauroylsarkosine; SIGMA) was added and incubated
at room temperature for 60 min, during which the solution was
mixed occasionally. The inner membrane proteins were solubilized
at this step. The mixture was centrifuged at 15,600 x g for 30 min at
4uC. The supernatant was kept as the soluble inner membrane
fraction. The pellet was washed with 0.5 ml of 10 mM HEPES
buffer followed by resuspension in 200 ml of 10 mMHEPES buffer.
This fraction was the outer membrane fraction. The fractions were
analyzed by SDS-PAGE and immunoblotting.
Adhesion assays
Adhesion assays were performed according to the method
described by Jin et al. [20], with some modifications. INT 407
cells (ATCC CCL-6) were grown in Minimum Essential Medium
(MEM) (GIBCO, Invitrogen) containing 10% fetal bovine serum
(FBS), 100 mg/ml streptomycin, and 100 units/ml penicillin G
(GIBCO, Invitrogen) at 37uC under the atmosphere of 5% CO2.
Once the INT 407 cells became confluent, the monolayers were
trypsinized and approximately 16105 cells/well in MEM with 10%
FBS without antibiotics were applied to each well of a 24-well tissue
culture plate, which was incubated at 37uC for 18 h under the
atmosphere of 5% CO2. The monolayers were washed twice with
1 x PBS. Overnight fresh cultures of NCTC 11168, Cj892, Cj912,
and Comp91 were added to wells containing monolayers in 1 ml of
MEM with 10% FBS at an INT 407 cells-to-bacteria ratio of 1:100,
and incubated at 37uC under the atmosphere of 5% CO2 for 3 h.
The monolayers were washed five times with 1 x PBS. The washed
monolayers were then lysed with 0.2 ml of 1% (w/v) Triton X-100
in PBS for 15 min. The Campylobacter cells were enumerated by plate
counting on MH agar plates. All assays were repeated three times
and were done in quadruplicate.
Motility assay
Bacterial strains were grown overnight and their OD600 was
adjusted to ca. 0.5. A single stab inoculation was made in the
center of the soft agar (0.4%; wt/vol) and the plates were
incubated at 42uC for 48 hours. The swarming diameters of the
strains were measured at the widest portion of the swarm halo.
Colonization in chicken
To examine whether the mutations of cj0089 and cj0091
affected C. jejuni colonization in chickens, 3-day-old commercial
broilers (Ross x Cobb), purchased from a commercial hatchery,
were inoculated via oral gavage with approximately 107 CFU of
NCTC 11168, Cj892, Cj912, or Comp91 (each group consists of
15 birds). At necropsy, cecal samples were collected from 5 birds
from each group at 3, 6, and 10 days post inoculation (DPI),
homogenized, serially diluted in 1 x PBS, and plated on MH plates
containing Campylobacter-specific selective agents and growth
supplements (SR084E and SR117E; Oxoid). After two-day
incubation at 42uC under microaerophilic conditions, the
Campylobacter colonies were counted.
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